Visa stock price holds near $326 as earnings week and the Fed loom

Visa stock price holds near $326 as earnings week and the Fed loom

New York, Jan 25, 2026, 10:36 EST — The market has closed.

  • Visa shares dipped 0.06% Friday, ending the day at $326.18
  • Visa will release its fiscal first-quarter results after the bell on Jan. 29
  • On Jan. 27-28, the Fed holds its meeting; Mastercard and American Express will also release earnings this week

Visa shares slipped 0.06% to close at $326.18 on Friday, just below Thursday’s finish. The stock fluctuated between $324.62 and $327.80 during the session. It remains roughly 13% under its 52-week peak of $375.51, with volume around 5.7 million shares traded. (Visa)

As U.S. markets remain closed over the weekend, attention turns to the Federal Reserve’s upcoming meeting on Jan. 27-28. Investors will be watching closely for the policy statement scheduled for 2 p.m. ET Wednesday, followed by Chair Jerome Powell’s press conference at 2:30 p.m. ET. Visa’s data on spending is particularly noteworthy since the networks capture transaction trends ahead of most retailers. (Federal Reserve)

JPMorgan’s Tien-tsin Huang noted that recent spending figures show just a modest slowdown in Q4, indicating the domestic consumer remains resilient despite tough comparisons from last year. He also highlighted renewed focus on the Credit Card Competition Act, which aims to open credit-card routing to more networks. Still, Huang said any impact on Visa and Mastercard would probably be manageable over time. (Benzinga)

Visa announced it will release fiscal first-quarter results Thursday, Jan. 29, after the market closes, followed by a webcast at 5 p.m. ET. The company remains in its usual “quiet period,” restricting executive contact with investors until the report is out. (Visa)

Traders are focused on updates around payment volume, processed transactions, and cross-border spending—purchases made on cards outside their issuing country, which usually reflects travel trends. They’ll also pay close attention to any remarks on “client incentives,” the fees Visa offers issuing banks and partners to maintain card usage and transaction volume on its network.

Visa’s annual meeting is scheduled for Tuesday, Jan. 27, and will take place virtually, according to a proxy filing. In a letter to shareholders, CEO Ryan McInerney highlighted that in 2025, the company advanced product development “in dynamic areas including AI and stablecoins.” (SEC)

Mastercard will report earnings on Jan. 29, holding a conference call at 9 a.m. ET. American Express follows the next day, with its quarterly call scheduled for 8:30 a.m. ET on Jan. 30. (Mastercard)

One key macro indicator tied closely to major consumer earnings is absent from Thursday’s U.S. data lineup: the Bureau of Economic Analysis delayed the advance GDP report for Q4 and the December personal income and outlays report until Feb. 20, as it adjusts its post-shutdown release calendar. (Bureau of Economic Analysis)

The setup isn’t straightforward. A steeper slowdown in travel and discretionary spending would hit cross-border volume fast, while regulators are still zeroed in on fees. In Britain, a court recently upheld the payments regulator’s authority to cap cross-border card fees. Visa warned that such limits could “negatively impact the value people and businesses receive.” (Reuters)

Visa enters the week without much momentum in either direction. Investors are eyeing the Fed’s Wednesday decision and Visa’s earnings report after Thursday’s close.

Stock Market Today

  • Novo Nordisk Shares Seen as Undervalued Despite 27.8% Drop Over Past Year
    January 25, 2026, 10:48 AM EST. Novo Nordisk's (NYSE:NVO) stock has declined 27.8% over the past year but gained 18.8% in the last month. Despite this, a discounted cash flow (DCF) model estimates an intrinsic value of $149.81 per share, suggesting shares trade at a 58.4% discount to fair value. Novo Nordisk scored 5 out of 6 on Simply Wall St's valuation framework, indicating undervaluation on most metrics. Analysts forecast free cash flow growth through 2030, supporting bullish long-term prospects. The recent mixed return profile and ongoing interest as a leading pharma firm frame current investor debates on valuation and risks. Novo Nordisk remains a key biotech name under close watch for potential upside against recent price weakness.
Tencent stock price: Nvidia H200 chip orders loom as 0700.HK heads into Monday
Previous Story

Tencent stock price: Nvidia H200 chip orders loom as 0700.HK heads into Monday

Go toTop